White Paper
Uncovering Insights: Tapping into APAC's Potential for Obesity Clinical Trials
A Survey Across Ten Asia Pacific Countries
Jul 10, 2025
Download

Obesity is a growing public health concern in the Asia

Pacific region, posing significant health and economic challenges. Thus, effective and holistic obesity management is essential.

The diagnosis and management of obesity in the region is aligned with global recommendations and practices. In addition to lifestyle modification, pharmacotherapy is used as an adjunct to achieve and maintain weight loss goals. Improving the efficacy and safety profile of anti-obesity drugs should be the focus of future research and development.

The rising prevalence of obesity in the region, the expertise of investigators in evaluating and managing overweight and obese patients, their experience in the use of anti-obesity drugs, and their clinical trial exposure and interest, make the Asia Pacific region a promising environment for expanding clinical trials in obesity.

Related solutions

Contact Us